An integrated assay using proprietary RNAscope™ and miRNAscope™ technologies to measure the biodistribution and function of novel gene therapies and endogenous regulatory RNAs. Small regulatory RNAs, ...
(RTTNews) - Bio-Techne (TECH), a US-based biotechnology company Thursday has introduced an expanded range of human and mouse RNAscope in situ hybridization probes to support spatial biology research ...
The RNAscope in situ hybridization (ISH) technology is a powerful method for detecting gene expression with spatial and morphological tissue context. In this webinar, we will focus on an Integrated Co ...
MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...
Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, and Bio-Techne (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, ...
Advanced Cell Diagnostics (ACD), a company recently acquired by Bio-Techne, has introduced assays that promise to transform molecular pathology. These assays can detect and quantify RNA in situ while ...
Gene therapy is becoming a reality for the treatment of several conditions, but preclinical evaluation still presents a challenge 1. Adverum Biotechnologies overcame these hurdles to achieve FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results